Published in Obes Surg on December 17, 2004
Gastric Bypass After Previous Anti-reflux Surgery (RYGBafterARS) | NCT01041105
Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59
Laparoscopic revision of Nissen fundoplication to Roux-en-Y gastric bypass in morbidly obese patients. Surg Endosc (2008) 0.91
The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc (2008) 0.89
Revisional bariatric surgery: perioperative morbidity is determined by type of procedure. Surg Endosc (2013) 0.88
The role of short-limb Roux-en-Y reconstruction for failed antireflux surgery: a single-center 5-year experience. Surg Endosc (2011) 0.85
The effect of bariatric surgery on gastroesophageal reflux disease. Can J Surg (2014) 0.85
Laparoscopic fundoplication takedown with conversion to Roux-en-Y gastric bypass leads to excellent reflux control and quality of life after fundoplication failure. Surg Endosc (2012) 0.84
Long-term outcomes of reintervention for failed fundoplication: redo fundoplication versus Roux-en-Y reconstruction. Surg Endosc (2013) 0.81
Combined treatment of symptomatic massive paraesophageal hernia in the morbidly obese. JSLS (2011) 0.80
Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver (2016) 0.78
Laparoscopic anti-reflux surgery is effective in obese patients with gastro-oesophageal reflux disease. Ann R Coll Surg Engl (2007) 0.76
The impact of previous fundoplication on laparoscopic gastric bypass outcomes: a case-control evaluation. Surg Endosc (2011) 0.75
Treatment of giant hiatal hernia by laparoscopic Roux-en-Y gastric bypass. Int J Surg Case Rep (2015) 0.75
The Belsey Mark IV: an operation with an enduring role in the management of complicated hiatal hernia. BMC Surg (2013) 0.75
Impact of concomitant laparoscopic sleeve gastrectomy and hiatal hernia repair on gastro-oesophageal reflux disease in morbidly obese patients. J Minim Access Surg (2017) 0.75
Oesophageal carcinoma. Lancet (2013) 5.48
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med (2015) 4.35
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. Surg Obes Relat Dis (2007) 3.67
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem (2005) 3.42
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg (2007) 2.85
Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry (2007) 2.80
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg (2007) 2.48
Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg (2012) 2.44
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg (2012) 2.14
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg (2006) 2.12
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg (2003) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Prevalence of alcohol use disorders before and after bariatric surgery. JAMA (2012) 2.02
Physical activity levels of patients undergoing bariatric surgery in the Longitudinal Assessment of Bariatric Surgery study. Surg Obes Relat Dis (2008) 1.91
Minimally invasive operation for esophageal diverticula. Ann Thorac Surg (2005) 1.90
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surg Obes Relat Dis (2013) 1.70
Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg (2009) 1.68
Optimizing long-term weight control after bariatric surgery: a pilot study. Surg Obes Relat Dis (2011) 1.68
Cervical pharyngostomy: an old technique revisited. Ann Surg (2008) 1.63
Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study. Surg Obes Relat Dis (2009) 1.63
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res (2008) 1.63
The laparoscopic approach to paraesophageal hernia repair. J Gastrointest Surg (2011) 1.62
Resection for esophageal cancer: strategies for optimal management. Ann Thorac Surg (2008) 1.60
Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol (2007) 1.60
Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51
Validity of self-reported weights following bariatric surgery. JAMA (2013) 1.51
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Should endobronchial ultrasonography be part of the thoracic surgeon's armamentarium? J Thorac Cardiovasc Surg (2009) 1.45
Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg (2008) 1.44
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc (2008) 1.43
Relationship of body mass index with demographic and clinical characteristics in the Longitudinal Assessment of Bariatric Surgery (LABS). Surg Obes Relat Dis (2008) 1.41
Contemporaneous management of esophageal perforation. Surgery (2009) 1.41
Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg (2011) 1.41
Anterior minithoracotomy: a direct approach to the difficult hilum for upper lobectomy, pneumonectomy, and sleeve lobectomy. Ann Surg Oncol (2009) 1.38
Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy. Ann Thorac Surg (2009) 1.37
Technique of minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2010) 1.32
Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg (2007) 1.31
Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem (2007) 1.30
Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2006) 1.28
Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.28
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg (2005) 1.27
Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg (2008) 1.24
Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.23
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia (2006) 1.22
Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg (2012) 1.21
Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg (2009) 1.21
The management of flail chest. Thorac Surg Clin (2007) 1.20
Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res (2011) 1.20
Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer (2004) 1.20
Pre- to postoperative changes in physical activity: report from the longitudinal assessment of bariatric surgery-2 (LABS-2). Surg Obes Relat Dis (2011) 1.19
Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis (2008) 1.17
Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg (2008) 1.17
Laparoscopic and thoracoscopic esophagectomy. Adv Surg (2010) 1.15
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. J Thorac Cardiovasc Surg (2011) 1.15
Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res (2004) 1.14
Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma. Ann Thorac Surg (2007) 1.13
Patterns of recurrence and long-term survival after curative resection of localized fibrous tumors of the pleura. Clin Lung Cancer (2005) 1.12
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia (2005) 1.12
Sublobar resection for early-stage lung cancer. Semin Thorac Cardiovasc Surg (2010) 1.11
Esophageal cancer: an update. Int J Surg (2010) 1.10
MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg (2011) 1.10
Psychiatric evaluation and follow-up of bariatric surgery patients. Am J Psychiatry (2009) 1.09
Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg (2011) 1.08
Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors. J Surg Res (2009) 1.07
Anatomic segmentectomy for stage I non-small-cell lung cancer: comparison of video-assisted thoracic surgery versus open approach. J Thorac Cardiovasc Surg (2009) 1.07
Minimally invasive esophagectomy. Surg Clin North Am (2012) 1.07
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J Clin Oncol (2013) 1.06
Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res (2005) 1.06
Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem (2004) 1.06
Minimally invasive esophagectomy for caustic esophageal stricture in children. J Pediatr Surg (2004) 1.05
Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients. JSLS (2004) 1.05
Long-term outcomes of laparoscopic Heller myotomy for achalasia. Surgery (2009) 1.05
The "best operation" for esophageal cancer? Ann Thorac Surg (2010) 1.03
Acute, complete proximal small bowel obstruction after laparoscopic gastric bypass due to intraluminal blood clot formation. Surg Obes Relat Dis (2005) 1.03
The effect of obesity in adolescence on adult health status. Pediatrics (2013) 1.03
Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg (2009) 1.03
Solitary sites of metastatic disease in non-small cell lung cancer. Curr Treat Options Oncol (2003) 1.03
Surgical management of epiphrenic diverticula in the minimally invasive era. JSLS (2009) 1.02
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol (2011) 1.01
Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types. Lung Cancer (2003) 1.01
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg (2008) 0.97
Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg (2009) 0.97
Distribution of 10-year and lifetime predicted risk for cardiovascular disease prior to surgery in the longitudinal assessment of bariatric surgery-2 study. Am J Cardiol (2012) 0.96